Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccine for acute respiratory infection in elderly
NCT04938323Phase 3Withdrawn
- Sponsor
- Harvard Medical School
- Start
- May 2022
- Primary completion
- Jul 2022
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, double-blind trial in Acute Respiratory Infection (ARI) comparing BCG Vaccine with Placebo Arm (2 arms). Primary endpoint: Cumulative incidence of hospitalization for acute respiratory infection at 6 months. Planned start May 2022; status: withdrawn.
02
Drugs
bcg vaccine
03
Conditions
Acute Respiratory Infection (ARI)
Beyond the preview
Go deeper on NCT04938323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04938323.